Egetis Therapeutics AB (publ) EGTX.ST Stock
Egetis Therapeutics AB (publ) Price Chart
Egetis Therapeutics AB (publ) EGTX.ST Financial and Trading Overview
| Egetis Therapeutics AB (publ) stock price | 6.08 SEK |
| Previous Close | 5.06 SEK |
| Open | 5.1 SEK |
| Bid | 5.54 SEK x N/A |
| Ask | 5.58 SEK x N/A |
| Day's Range | 5 - 5.69 SEK |
| 52 Week Range | 3.03 - 9.2 SEK |
| Volume | 689.88K SEK |
| Avg. Volume | 794.91K SEK |
| Market Cap | 1.38B SEK |
| Beta (5Y Monthly) | 1.260153 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.8 SEK |
EGTX.ST Valuation Measures
| Enterprise Value | 1.07B SEK |
| Trailing P/E | N/A |
| Forward P/E | 7.4864864 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 62.005512 |
| Price/Book (mrq) | 2.1992853 |
| Enterprise Value/Revenue | 47.899 |
| Enterprise Value/EBITDA | -4.43 |
Trading Information
Egetis Therapeutics AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.260153 |
| 52-Week Change | 61.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.2 SEK |
| 52 Week Low | 3.03 SEK |
| 50-Day Moving Average | 7.26 SEK |
| 200-Day Moving Average | 5.56 SEK |
EGTX.ST Share Statistics
| Avg. Volume (3 month) | 794.91K SEK |
| Avg. Daily Volume (10-Days) | 806.09K SEK |
| Shares Outstanding | 249.59M |
| Float | 144.21M |
| Short Ratio | N/A |
| % Held by Insiders | 52.07% |
| % Held by Institutions | 17.19% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1087.44% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.032% |
| Return on Equity (ttm) | -42.54% |
Income Statement
| Revenue (ttm) | 22.3M SEK |
| Revenue Per Share (ttm) | 0.11 SEK |
| Quarterly Revenue Growth (yoy) | -4.20% |
| Gross Profit (ttm) | -120000000 SEK |
| EBITDA | -241100000 SEK |
| Net Income Avi to Common (ttm) | -239900000 SEK |
| Diluted EPS (ttm) | -1.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 243.5M SEK |
| Total Cash Per Share (mrq) | 0.98 SEK |
| Total Debt (mrq) | 3.8M SEK |
| Total Debt/Equity (mrq) | 0.6 SEK |
| Current Ratio (mrq) | 6.801 |
| Book Value Per Share (mrq) | 2.519 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -219800000 SEK |
| Levered Free Cash Flow (ttm) | -136710496 SEK |
Profile of Egetis Therapeutics AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Klara Norra Kyrkogata 26 |
| ZIP | 111 22 |
| Phone | 46 86 79 72 10 |
| Website | https://www.egetis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.
Q&A For Egetis Therapeutics AB (publ) Stock
What is a current EGTX.ST stock price?
Egetis Therapeutics AB (publ) EGTX.ST stock price today per share is 6.08 SEK.
How to purchase Egetis Therapeutics AB (publ) stock?
You can buy EGTX.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Egetis Therapeutics AB (publ)?
The stock symbol or ticker of Egetis Therapeutics AB (publ) is EGTX.ST.
Which industry does the Egetis Therapeutics AB (publ) company belong to?
The Egetis Therapeutics AB (publ) industry is Biotechnology.
How many shares does Egetis Therapeutics AB (publ) have in circulation?
The max supply of Egetis Therapeutics AB (publ) shares is 292.57M.
What is Egetis Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?
Egetis Therapeutics AB (publ) PE Ratio is now.
What was Egetis Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?
Egetis Therapeutics AB (publ) EPS is -1.4 SEK over the trailing 12 months.
Which sector does the Egetis Therapeutics AB (publ) company belong to?
The Egetis Therapeutics AB (publ) sector is Healthcare.
Egetis Therapeutics AB (publ) EGTX.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 435.1 SEK 42.47 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 349.01 EUR 381.52 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4086.93 SEK 398.94 USD |
-0.47
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5132.25 SEK 500.97 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1196.96 SEK 116.84 USD |
-0.26
|
— — | — — | — — | — - | — — |
| OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 517.93 ISK 3.81 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 349.16 DKK 51.19 USD |
-0.69
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 596.42 SEK 58.22 USD |
-0.19
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}